During a event titled 'A Discussion on Courage,' Lord Cameron and Andy Saperstein from Morgan Stanley delved into the impact of philanthropy on rare disease innovation. This took place in Oxford, England and Cleveland on September 10, 2025. The Oxford-Harrington Rare Disease Centre ('OHC'), formed through a collaboration, was at the center of the conversation.